Preview

Meditsinskiy sovet = Medical Council

Advanced search

RioFlora Balance Neo probiotic and anti-Helicobacter therapy: achieving greater treatment efficiency by reducing side effects

https://doi.org/10.21518/2079-701X-2013-10-100-103

Abstract

According to current standards, treatment of peptic ulcer disease in a majority of patients requires eradication of Helicobacter pylori. Latest antibiotics can achieve a high degree of eradication; however, clinical efficacy of treatment is determined not only by the effectiveness of eradication, epithelization of the ulcer, elimination of other symptoms of the disease, and the prognosis, but also by absence of side effects of the treatment.

About the Authors

I. A. Lee
Research Institute of Gastroenterology, Moscow
Russian Federation


S. Y. Silvestrova
Research Institute of Gastroenterology, Moscow
Russian Federation


V. N. Drozdov
Research Institute of Gastroenterology, Moscow
Russian Federation


References

1. H. pylori resistance and management strategies. World Congress of Gastroenterology. Montreal, 2005.

2. Maastricht–3 Guidelines for Helicobacter pylori infection. 13. United European Gastroenterology Week. Copenhagen, 2005.

3. Ардатская М.Д., Минушкин О.Н., Иконников Н.С. Дисбактериоз кишечника: понятие, диагностические подходы и пути коррекции. Возможности и преимущества биохимического исследования кала. Пособие для врачей. М., 2004.

4. Shindo K., Machida M., Fukumura M., Koide K., Yamazaki R. Omeprazole induces altered bile acid metabolism // Gut. 266. 1998. №42. Р. 266–271.

5. Brummer R.J., Stockbrger R.W.. Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24–hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer // Dig. Dis. Sci. 1996. №41(10). Р. 2048–2054.

6. Stark С.А., Adamsson I., Edlund C., Sjosted S. et al. Effects of omeprazole and amoxycillin on the human oral and gastrointestinal mic-roflora in patients with Helicobacter pylori infection // Journal of Antimicrobial Chemotherapy. 1996.№38. Р. 927–939.

7. Verdu E., Viani F., Armstrong D. et al. Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N–nitroso compounds // Gut. 1994. №35. Р. 455–460.

8. Златкина А.Р. Фармакотерапия хронических болезней органов пищеварения. М.: Медицина, 1998.

9. Adamsson I., Nord C.E., Lindquist P., Sj stedt S. et al. Comparative effects of omeprazole, amoxicillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole in the oral, gastric and intestinal microflora in Helicobacter pylori–infected patients // Journal of Antimicrobial Chemotherapy. 1999. №44(5). Р. 629–640.

10. Sjlund M., Wreiber K., Andersson K. et al. Long–Term Persistence of Resistant Enterococcus Species after Antibiotics To Eradicate Helicobacter pylori // Ann. Intern. Med. 2003. №139. Р. 483–487.

11. Skinner–Adams T., Davis T.M. Synergistic in vitro antimalarial activity of omeprazole and quinine // Antimicrob. Agents Chemother. 1999. №43(5). Р. 1304–1306.

12. Archer S.Y., Meng S., Shei A. et al. p21 (WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells // Proc. Natl. Acad. Sci. USA. 1998. №95. Р. 6791–6796.

13. Hague A., Diaz G.D., Hicks D.J. et al. Bcl-2 and bak may play a pivotal role in sodium butyrate – induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak-mediated apoptosis // Int. J. Cancer. 1997. №72. Р. 898–905.

14. Mariadason J.M., Velcich A., Wilson A.J. et al. Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation // Gastroenterology. 2001. №120. Р. 889–899.

15. Hague A., Elder D.J., Hicks D.J. et al. Apoptosis in colorectal tumor cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate // Int. J. Cancer. 1995. №60. Р. 400–406.


Review

For citations:


Lee IA, Silvestrova SY, Drozdov VN. RioFlora Balance Neo probiotic and anti-Helicobacter therapy: achieving greater treatment efficiency by reducing side effects. Meditsinskiy sovet = Medical Council. 2013;(10):100-103. (In Russ.) https://doi.org/10.21518/2079-701X-2013-10-100-103

Views: 459


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)